Marco Quarta’s senolytic patent credit
US patent US11026963B2 names Marco Quarta as one of three inventors and records an assignment of rights to Rubedo Life Sciences Inc.
Marco Quarta is a named inventor on a senolytic patent
Marco Quarta appears in Eternal Search as an investor. US patent US11026963B2 names him as one of three inventors alongside Mark A. Gallop and Julian Klein.
The patent, “Senolytic compositions and uses thereof,” was granted on June 8, 2021. The record lists an assignment of rights from the three inventors to Rubedo Life Sciences Inc in August 2019. This documents Quarta’s connection to the invention, but the supplied excerpt does not establish his individual technical contribution, the compositions’ mechanism, or their effectiveness. Assessing the invention itself requires examining the patent claims and experimental evidence.
US11026963B2: Senolytic compositions and uses thereof
Sources
[1] US11026963B2 - Senolytic compositions and uses thereof
The patent adds a documented inventor role to Quarta’s investor profile and gives readers a primary source they can inspect directly.